Cardiovascular magnetic resonance in the evaluation of heart valve disease

go back to reference Caduff JH, Hernandez RJ, Ludomirsky A. MR visualization of aortic valve vegetations. J Comput Assist Tomogr. 1996;20(4):613–5.CrossRefPubMed Caduff JH, Hernandez RJ, Ludomirsky A. MR visualization of aortic valve vegetations. J Comput Assist Tomogr. 1996;20(4):613–5.CrossRefPubMed

go back to reference Wintersperger BJ, Becker CR, Gulbins H, Knez A, Bruening R, Heuck A, et al. Tumors of the cardiac valves: imaging findings in magnetic resonance imaging, electron beam computed tomography, and echocardiography. Eur Radiol. 2000;10(3):443–9.CrossRefPubMed Wintersperger BJ, Becker CR, Gulbins H, Knez A, Bruening R, Heuck A, et al. Tumors of the cardiac valves: imaging findings in magnetic resonance imaging, electron beam computed tomography, and echocardiography. Eur Radiol. 2000;10(3):443–9.CrossRefPubMed

go back to reference Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:7.CrossRefPubMedPubMedCentral Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:7.CrossRefPubMedPubMedCentral

go back to reference Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation. 2009;119(3):468–78.CrossRefPubMed Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation. 2009;119(3):468–78.CrossRefPubMed

go back to reference Andersson C, Kihlberg J, Ebbers T, Lindstrom L, Carlhall CJ, Engvall JE. Phase-contrast MRI volume flow--a comparison of breath held and navigator based acquisitions. BMC Med Imaging. 2016;16:26.CrossRefPubMedPubMedCentral Andersson C, Kihlberg J, Ebbers T, Lindstrom L, Carlhall CJ, Engvall JE. Phase-contrast MRI volume flow--a comparison of breath held and navigator based acquisitions. BMC Med Imaging. 2016;16:26.CrossRefPubMedPubMedCentral

go back to reference Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, et al. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Am J Cardiol. 1995;75(17):1250–5.CrossRefPubMed Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, et al. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Am J Cardiol. 1995;75(17):1250–5.CrossRefPubMed

go back to reference Chatzimavroudis GP, Oshinski JN, Franch RH, Walker PG, Yoganathan AP, Pettigrew RI. Evaluation of the precision of magnetic resonance phase velocity mapping for blood flow measurements. J Cardiovasc Magn Reson. 2001;3(1):11–9.CrossRefPubMed Chatzimavroudis GP, Oshinski JN, Franch RH, Walker PG, Yoganathan AP, Pettigrew RI. Evaluation of the precision of magnetic resonance phase velocity mapping for blood flow measurements. J Cardiovasc Magn Reson. 2001;3(1):11–9.CrossRefPubMed

go back to reference Van Rossum AC, Sprenger M, Visser FC, Peels KH, Valk J, Roos JP. An in vivo validation of quantitative blood flow imaging in arteries and veins using magnetic resonance phase-shift techniques. Eur Heart J. 1991;12(2):117–26.CrossRefPubMed Van Rossum AC, Sprenger M, Visser FC, Peels KH, Valk J, Roos JP. An in vivo validation of quantitative blood flow imaging in arteries and veins using magnetic resonance phase-shift techniques. Eur Heart J. 1991;12(2):117–26.CrossRefPubMed

go back to reference Gatehouse PD, Rolf MP, Graves MJ, Hofman MB, Totman J, Werner B, et al. Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements. J Cardiovasc Magn Reson. 2010;12:5.CrossRefPubMedPubMedCentral Gatehouse PD, Rolf MP, Graves MJ, Hofman MB, Totman J, Werner B, et al. Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements. J Cardiovasc Magn Reson. 2010;12:5.CrossRefPubMedPubMedCentral

go back to reference Chernobelsky A, Shubayev O, Comeau CR, Wolff SD. Baseline correction of phase contrast images improves quantification of blood flow in the great vessels. J Cardiovasc Magn Reson. 2007;9(4):681–5.CrossRefPubMed Chernobelsky A, Shubayev O, Comeau CR, Wolff SD. Baseline correction of phase contrast images improves quantification of blood flow in the great vessels. J Cardiovasc Magn Reson. 2007;9(4):681–5.CrossRefPubMed

go back to reference Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34.CrossRefPubMed Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34.CrossRefPubMed

go back to reference Miller CA, Jordan P, Borg A, Argyle R, Clark D, Pearce K, et al. Quantification of left ventricular indices from SSFP cine imaging: impact of real-world variability in analysis methodology and utility of geometric modeling. J Magn Reson Imaging. 2013;37(5):1213–22.CrossRefPubMed Miller CA, Jordan P, Borg A, Argyle R, Clark D, Pearce K, et al. Quantification of left ventricular indices from SSFP cine imaging: impact of real-world variability in analysis methodology and utility of geometric modeling. J Magn Reson Imaging. 2013;37(5):1213–22.CrossRefPubMed

go back to reference Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.CrossRefPubMed Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.CrossRefPubMed

go back to reference Carabello BA. Clinical practice. Aortic stenosis N Engl J Med. 2002;346(9):677–82.CrossRefPubMed Carabello BA. Clinical practice. Aortic stenosis N Engl J Med. 2002;346(9):677–82.CrossRefPubMed

go back to reference Saikrishnan N, Kumar G, Sawaya FJ, Lerakis S, Yoganathan AP. Accurate assessment of aortic stenosis: a review of diagnostic modalities and hemodynamics. Circulation. 2014;129(2):244–53.CrossRefPubMed Saikrishnan N, Kumar G, Sawaya FJ, Lerakis S, Yoganathan AP. Accurate assessment of aortic stenosis: a review of diagnostic modalities and hemodynamics. Circulation. 2014;129(2):244–53.CrossRefPubMed

go back to reference Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–e132.CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–e132.CrossRefPubMed

go back to reference Reant P, Lederlin M, Lafitte S, Serri K, Montaudon M, Corneloup O, et al. Absolute assessment of aortic valve stenosis by planimetry using cardiovascular magnetic resonance imaging: comparison with transesophageal echocardiography, transthoracic echocardiography, and cardiac catheterisation. Eur J Radiol. 2006;59(2):276–83.CrossRefPubMed Reant P, Lederlin M, Lafitte S, Serri K, Montaudon M, Corneloup O, et al. Absolute assessment of aortic valve stenosis by planimetry using cardiovascular magnetic resonance imaging: comparison with transesophageal echocardiography, transthoracic echocardiography, and cardiac catheterisation. Eur J Radiol. 2006;59(2):276–83.CrossRefPubMed

go back to reference Buchner S, Debl K, Schmid FX, Luchner A, Djavidani B. Cardiovascular magnetic resonance assessment of the aortic valve stenosis: an in vivo and ex vivo study. BMC Med Imaging. 2015;15:34.CrossRefPubMedPubMedCentral Buchner S, Debl K, Schmid FX, Luchner A, Djavidani B. Cardiovascular magnetic resonance assessment of the aortic valve stenosis: an in vivo and ex vivo study. BMC Med Imaging. 2015;15:34.CrossRefPubMedPubMedCentral

go back to reference Singh A, Ford I, Greenwood JP, Khan JN, Uddin A, Berry C, et al. Rationale and design of the PRognostic importance of MIcrovascular dysfunction in asymptomatic patients with aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations. BMJ Open. 2013;3(12):e004348.CrossRefPubMedPubMedCentral Singh A, Ford I, Greenwood JP, Khan JN, Uddin A, Berry C, et al. Rationale and design of the PRognostic importance of MIcrovascular dysfunction in asymptomatic patients with aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations. BMJ Open. 2013;3(12):e004348.CrossRefPubMedPubMedCentral

go back to reference Bissell MM, Hess AT, Biasiolli L, Glaze SJ, Loudon M, Pitcher A, et al. Aortic dilation in bicuspid aortic valve disease: flow pattern is a major contributor and differs with valve fusion type. Circ Cardiovasc Imaging. 2013;6(4):499–507.CrossRefPubMed Bissell MM, Hess AT, Biasiolli L, Glaze SJ, Loudon M, Pitcher A, et al. Aortic dilation in bicuspid aortic valve disease: flow pattern is a major contributor and differs with valve fusion type. Circ Cardiovasc Imaging. 2013;6(4):499–507.CrossRefPubMed

go back to reference Girdauskas E, Borger MA, Secknus MA, Girdauskas G, Kuntze T. Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument. Eur J Cardiothorac Surg. 2011;39(6):809–14.CrossRefPubMed Girdauskas E, Borger MA, Secknus MA, Girdauskas G, Kuntze T. Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument. Eur J Cardiothorac Surg. 2011;39(6):809–14.CrossRefPubMed

go back to reference Cavalcante JL, Schoenhagen P. Role of cross-sectional imaging for structural heart disease interventions. Cardiol Clin. 2013;31(3):467–78.CrossRefPubMed Cavalcante JL, Schoenhagen P. Role of cross-sectional imaging for structural heart disease interventions. Cardiol Clin. 2013;31(3):467–78.CrossRefPubMed

go back to reference Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S, et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart. 2006;92(10):1447–51.CrossRefPubMedPubMedCentral Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S, et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart. 2006;92(10):1447–51.CrossRefPubMedPubMedCentral

go back to reference Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58(12):1271–9.CrossRefPubMed Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58(12):1271–9.CrossRefPubMed

go back to reference Nigri M, Azevedo CF, Rochitte CE, Schraibman V, Tarasoutchi F, Pommerantzeff PM, et al. Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: correlation with quantitative histopathology. Am Heart J. 2009;157(2):361–8.CrossRefPubMed Nigri M, Azevedo CF, Rochitte CE, Schraibman V, Tarasoutchi F, Pommerantzeff PM, et al. Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: correlation with quantitative histopathology. Am Heart J. 2009;157(2):361–8.CrossRefPubMed

go back to reference Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99(13):932–7.CrossRefPubMedPubMedCentral Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99(13):932–7.CrossRefPubMedPubMedCentral

go back to reference Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107(7):984–91.CrossRefPubMed Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107(7):984–91.CrossRefPubMed

go back to reference Chin CW, Everett RJ, Kwiecinski J, Vesey AT, Yeung E, Esson G, et al. Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis. JACC Cardiovasc Imaging. 2016. Chin CW, Everett RJ, Kwiecinski J, Vesey AT, Yeung E, Esson G, et al. Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis. JACC Cardiovasc Imaging. 2016.

go back to reference Everett RJ, Newby DE, Jabbour A, Fayad ZA, Dweck MR. The role of imaging in aortic valve disease. Curr Cardiovasc Imaging Rep. 2016;9:21.CrossRefPubMedPubMedCentral Everett RJ, Newby DE, Jabbour A, Fayad ZA, Dweck MR. The role of imaging in aortic valve disease. Curr Cardiovasc Imaging Rep. 2016;9:21.CrossRefPubMedPubMedCentral

go back to reference Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.CrossRefPubMed

go back to reference Myerson SG, d'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM, et al. Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation. 2012;126(12):1452–60.CrossRefPubMed Myerson SG, d'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM, et al. Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation. 2012;126(12):1452–60.CrossRefPubMed

go back to reference Chatzimavroudis GP, Oshinski JN, Franch RH, Pettigrew RI, Walker PG, Yoganathan AP. Quantification of the aortic regurgitant volume with magnetic resonance phase velocity mapping: a clinical investigation of the importance of imaging slice location. J Heart Valve Dis. 1998;7(1):94–101.PubMed Chatzimavroudis GP, Oshinski JN, Franch RH, Pettigrew RI, Walker PG, Yoganathan AP. Quantification of the aortic regurgitant volume with magnetic resonance phase velocity mapping: a clinical investigation of the importance of imaging slice location. J Heart Valve Dis. 1998;7(1):94–101.PubMed

go back to reference Bertelsen L, Svendsen JH, Kober L, Haugan K, Hojberg S, Thomsen C, et al. Flow measurement at the aortic root - impact of location of through-plane phase contrast velocity mapping. J Cardiovasc Magn Reson. 2016;18(1):55.CrossRefPubMedPubMedCentral Bertelsen L, Svendsen JH, Kober L, Haugan K, Hojberg S, Thomsen C, et al. Flow measurement at the aortic root - impact of location of through-plane phase contrast velocity mapping. J Cardiovasc Magn Reson. 2016;18(1):55.CrossRefPubMedPubMedCentral

go back to reference Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6(1):48–57.CrossRefPubMed Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6(1):48–57.CrossRefPubMed

go back to reference Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J. 1991;12(Suppl B):55–60.CrossRefPubMed Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J. 1991;12(Suppl B):55–60.CrossRefPubMed

go back to reference Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112(3):432–7.CrossRefPubMed Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112(3):432–7.CrossRefPubMed

go back to reference Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):e521–643.CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):e521–643.CrossRefPubMed

go back to reference Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23. quiz 101-2CrossRefPubMed Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23. quiz 101-2CrossRefPubMed

go back to reference Heidenreich PA, Steffens J, Fujita N, O'Sullivan M, Caputo GR, Foster E, et al. Evaluation of mitral stenosis with velocity-encoded cine-magnetic resonance imaging. Am J Cardiol. 1995;75(5):365–9.CrossRefPubMed Heidenreich PA, Steffens J, Fujita N, O'Sullivan M, Caputo GR, Foster E, et al. Evaluation of mitral stenosis with velocity-encoded cine-magnetic resonance imaging. Am J Cardiol. 1995;75(5):365–9.CrossRefPubMed

go back to reference Lin SJ, Brown PA, Watkins MP, Williams TA, Lehr KA, Liu W, et al. Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound. J Am Coll Cardiol. 2004;44(1):133–7.CrossRefPubMed Lin SJ, Brown PA, Watkins MP, Williams TA, Lehr KA, Liu W, et al. Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound. J Am Coll Cardiol. 2004;44(1):133–7.CrossRefPubMed

go back to reference Myerson SG, Francis JM, Neubauer S. Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability. MAGMA. 2010;23(4):243–9.CrossRefPubMed Myerson SG, Francis JM, Neubauer S. Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability. MAGMA. 2010;23(4):243–9.CrossRefPubMed

go back to reference Harb SC, Griffin BP. Mitral valve disease: a comprehensive review. Curr Cardiol Rep. 2017;19(8):73.CrossRefPubMed Harb SC, Griffin BP. Mitral valve disease: a comprehensive review. Curr Cardiol Rep. 2017;19(8):73.CrossRefPubMed

go back to reference Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94.CrossRefPubMed Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94.CrossRefPubMed

go back to reference Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875–83.CrossRefPubMed Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875–83.CrossRefPubMed

go back to reference Van De Heyning CM, Magne J, Pierard LA, Bruyere PJ, Davin L, De Maeyer C, et al. Assessment of left ventricular volumes and primary mitral regurgitation severity by 2D echocardiography and cardiovascular magnetic resonance. Cardiovasc Ultrasound. 2013;11:46.CrossRefPubMedPubMedCentral Van De Heyning CM, Magne J, Pierard LA, Bruyere PJ, Davin L, De Maeyer C, et al. Assessment of left ventricular volumes and primary mitral regurgitation severity by 2D echocardiography and cardiovascular magnetic resonance. Cardiovasc Ultrasound. 2013;11:46.CrossRefPubMedPubMedCentral

go back to reference Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015;65(11):1078–88.CrossRefPubMed Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015;65(11):1078–88.CrossRefPubMed

go back to reference Myerson SG, d'Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM, et al. Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification. Circulation. 2016;133(23):2287–96.CrossRefPubMed Myerson SG, d'Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM, et al. Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification. Circulation. 2016;133(23):2287–96.CrossRefPubMed

go back to reference Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation. 1993;88(5 Pt 1):2257–66.CrossRefPubMed Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation. 1993;88(5 Pt 1):2257–66.CrossRefPubMed

go back to reference Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Taliercio CP, Taylor CL, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr. 1990;3(1):54–63.CrossRefPubMed Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Taliercio CP, Taylor CL, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr. 1990;3(1):54–63.CrossRefPubMed

go back to reference Ammash NM, Dearani JA, Burkhart HM, Connolly HM. Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Congenit Heart Dis. 2007;2(6):386–403.CrossRefPubMed Ammash NM, Dearani JA, Burkhart HM, Connolly HM. Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Congenit Heart Dis. 2007;2(6):386–403.CrossRefPubMed

go back to reference Shellock FG. MR imaging of metallic implants and materials: a compilation of the literature. AJR Am J Roentgenol. 1988;151(4):811–4.CrossRefPubMed Shellock FG. MR imaging of metallic implants and materials: a compilation of the literature. AJR Am J Roentgenol. 1988;151(4):811–4.CrossRefPubMed

go back to reference Hasenkam JM, Ringgaard S, Houlind K, Botnar RM, Stodkilder-Jorgensen H, Boesiger P, et al. Prosthetic heart valve evaluation by magnetic resonance imaging. Eur J Cardiothorac Surg. 1991;16:300–5.CrossRef Hasenkam JM, Ringgaard S, Houlind K, Botnar RM, Stodkilder-Jorgensen H, Boesiger P, et al. Prosthetic heart valve evaluation by magnetic resonance imaging. Eur J Cardiothorac Surg. 1991;16:300–5.CrossRef

go back to reference Cardiology ESo. MRI evaluation in patients with prosthetic valves: European Society of Cardiology; 2016 [Available from: http://www.escardio.org/Education/Practice-Tools/EACVI-toolboxes/Valvular-Imaging/Atlas-of-valvular-imaging/Prosthetic-valves/MRI-evaluation-in-patients-with-prosthetic-valves. Cardiology ESo. MRI evaluation in patients with prosthetic valves: European Society of Cardiology; 2016 [Available from: http://​www.​escardio.​org/​Education/​Practice-Tools/​EACVI-toolboxes/​Valvular-Imaging/​Atlas-of-valvular-imaging/​Prosthetic-valves/​MRI-evaluation-in-patients-with-prosthetic-valves.

go back to reference Sensky PR, Loubani M, Keal RP, Samani NJ, Sosnowski AW, Galinanes M. Does the type of prosthesis influence early left ventricular mass regression after aortic valve replacement? Assessment with magnetic resonance imaging. Am Heart J. 2003;146(4):E13.CrossRefPubMed Sensky PR, Loubani M, Keal RP, Samani NJ, Sosnowski AW, Galinanes M. Does the type of prosthesis influence early left ventricular mass regression after aortic valve replacement? Assessment with magnetic resonance imaging. Am Heart J. 2003;146(4):E13.CrossRefPubMed

go back to reference Fairbairn TA, Steadman CD, Mather AN, Motwani M, Blackman DJ, Plein S, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013;99(16):1185–91.CrossRefPubMedPubMedCentral Fairbairn TA, Steadman CD, Mather AN, Motwani M, Blackman DJ, Plein S, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013;99(16):1185–91.CrossRefPubMedPubMedCentral

go back to reference American College of Cardiology/American Heart Association Task Force on Practice G, Society of Cardiovascular A, Society for Cardiovascular A, Interventions, Society of Thoracic S, Bonow RO, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114(5):e84–231.CrossRef American College of Cardiology/American Heart Association Task Force on Practice G, Society of Cardiovascular A, Society for Cardiovascular A, Interventions, Society of Thoracic S, Bonow RO, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114(5):e84–231.CrossRef

go back to reference Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307–32.CrossRefPubMed Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307–32.CrossRefPubMed